TY  - JOUR 
AU  - García Campelo, María del Rosario
PY  - 2014
SN  - 1078-0432
UR  - http://hdl.handle.net/20.500.11940/8447
LA  - eng
TI  - The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trial
DO  - 10.1158/1078-0432.ccr-13-2233
T2  - CLINICAL CANCER RESEARCH
M2  - 2001
VL  - 20
ER  -